Abbott says market overestimating sales hit from new diabetes drugs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Abbott (ABT) gains as 'strong' performance tops Q3 expectations
October 18, 2023 8:04 AM EDTAbbott (NYSE: ABT) shares are up more than 2% premarket Wednesday after the company reported earnings, topping consensus expectations.
The medical device company reported Q3 EPS of $1.14, $0.04 better than the analyst estimate of $1.10, while revenue for the quarter came in at $10.1 billion versus the consensus... More
